Fatigue in Patients with Chronic Hepatitis B Living in North America: Results from the Hepatitis B Research Network (HBRN)
- PMID: 26831489
- PMCID: PMC4791302
- DOI: 10.1007/s10620-015-4006-0
Fatigue in Patients with Chronic Hepatitis B Living in North America: Results from the Hepatitis B Research Network (HBRN)
Abstract
Background: Fatigue is a common symptom of liver disease but not well characterized in patients with chronic hepatitis B virus (HBV).
Aims: We assessed the rate of fatigue using a validated instrument in patients with HBV and identified demographic, virologic, and clinical features associated with fatigue in a cross-sectional cohort study from the Hepatitis B Research Network.
Methods: Participants were English- and Spanish-speaking adults with chronic HBV who were not pregnant nor on treatment. Fatigue was measured using the PROMIS® Fatigue 7-item Short Form.
Results: The sample included 948 adults: median age 42; 51 % female; 71 % Asian; 74 % college educated; 77 % employed; 41 % inactive HBV carriers; 36 % with active chronic disease; and 2 % with advanced fibrosis, defined as AST-platelet ratio index (APRI) > 1.50. Patients with chronic HBV had a mean fatigue T-score of 46.8 ± SD = 7.9, compared to a mean fatigue T-score of 50.0 ± 10 in the US general population (p < .0001). In univariate analyses, greater fatigue was associated with demographic and clinical features such as female sex, lower income, more comorbidities, higher APRI score, and poorer mental health (p < 0.05). In multivariate analysis, female sex (p < .001), poorer mental health (p < .001), APRI score (p = .005), and history of diabetes (p = .039) were the strongest independent predictors.
Conclusions: The frequency of fatigue in this large cohort of North American chronic HBV patients may be equal to or lower than that reported in the US general population. Patients with advanced fibrosis, more comorbidities, and poorer mental health report worse fatigue.
Keywords: Liver; Mental health; PROMIS; Patient-reported outcomes; Symptoms.
Figures


Comment in
-
Tired of Hepatitis B?Dig Dis Sci. 2016 Apr;61(4):953-4. doi: 10.1007/s10620-016-4067-8. Dig Dis Sci. 2016. PMID: 26874692 Free PMC article. No abstract available.
Similar articles
-
Patient-reported outcomes in a large North American cohort living with chronic hepatitis B virus: a cross-sectional analysis.Aliment Pharmacol Ther. 2020 Feb;51(4):457-468. doi: 10.1111/apt.15618. Epub 2020 Jan 14. Aliment Pharmacol Ther. 2020. PMID: 31943262 Free PMC article.
-
Transient elastography, APRI, and ultrasound have minimal utility in chronic low-replicative hepatitis B infection.Eur J Gastroenterol Hepatol. 2014 Sep;26(9):1010-4. doi: 10.1097/MEG.0000000000000165. Eur J Gastroenterol Hepatol. 2014. PMID: 25051218
-
Relationship Between Metabolic Syndrome, Alanine Aminotransferase Levels, and Liver Disease Severity in a Multiethnic North American Cohort With Chronic Hepatitis B.Diabetes Care. 2018 Jun;41(6):1251-1259. doi: 10.2337/dc18-0040. Epub 2018 Mar 29. Diabetes Care. 2018. PMID: 29599296 Free PMC article.
-
Coinfection of Schistosoma Species with Hepatitis B or Hepatitis C Viruses.Adv Parasitol. 2016;91:111-231. doi: 10.1016/bs.apar.2015.12.003. Epub 2016 Feb 5. Adv Parasitol. 2016. PMID: 27015949 Review.
-
NIH consensus development statement on management of hepatitis B.NIH Consens State Sci Statements. 2008 Oct 22-24;25(2):1-29. NIH Consens State Sci Statements. 2008. PMID: 18949020
Cited by
-
Patient-reported outcomes in a large North American cohort living with chronic hepatitis B virus: a cross-sectional analysis.Aliment Pharmacol Ther. 2020 Feb;51(4):457-468. doi: 10.1111/apt.15618. Epub 2020 Jan 14. Aliment Pharmacol Ther. 2020. PMID: 31943262 Free PMC article.
-
Community-based sero-prevalence of hepatitis B and C infections in South Omo Zone, Southern Ethiopia.PLoS One. 2019 Dec 30;14(12):e0226890. doi: 10.1371/journal.pone.0226890. eCollection 2019. PLoS One. 2019. PMID: 31887192 Free PMC article.
-
Impact of clinical and sociodemographic factors on fatigue among patients with substance use disorder: a cohort study from Norway for the period 2016-2020.Subst Abuse Treat Prev Policy. 2020 Dec 14;15(1):93. doi: 10.1186/s13011-020-00334-x. Subst Abuse Treat Prev Policy. 2020. PMID: 33317568 Free PMC article.
-
Chronic hepatitis D associated with worse patient-reported outcomes than chronic hepatitis B.JHEP Rep. 2021 Mar 17;3(3):100280. doi: 10.1016/j.jhepr.2021.100280. eCollection 2021 Jun. JHEP Rep. 2021. PMID: 34041466 Free PMC article.
-
Risk factors associated with fatigue in chronic hepatitis B patients.Patient Prefer Adherence. 2019 Jul 4;13:1065-1072. doi: 10.2147/PPA.S206953. eCollection 2019. Patient Prefer Adherence. 2019. PMID: 31456634 Free PMC article.
References
-
- Lok AS, McMahon BJ. Chronic hepatitis B: update 2009. Hepatology. 2009;50(3):661–2. - PubMed
-
- Ozkan M, Corapcioglu A, Balcioglu I, Ertekin E, Khan S, Ozdemir S, et al. Psychiatric morbidity and its effect on the quality of life of patients with chronic hepatitis B and hepatitis C. International journal of psychiatry in medicine. 2006;36(3):283–97. - PubMed
-
- Modabbernia A, Ashrafi M, Malekzadeh R, Poustchi H. A review of psychosocial issues in patients with chronic hepatitis B. Archives of Iranian medicine. 2013;16(2):114–22. - PubMed
Publication types
MeSH terms
Grants and funding
- UL1 TR000433/TR/NCATS NIH HHS/United States
- DK082871/DK/NIDDK NIH HHS/United States
- U01 DK082919/DK/NIDDK NIH HHS/United States
- U01 DK082927/DK/NIDDK NIH HHS/United States
- U01 DK082872/DK/NIDDK NIH HHS/United States
- UL1 TR001111/TR/NCATS NIH HHS/United States
- K23 DK089004/DK/NIDDK NIH HHS/United States
- U01 DK082943/DK/NIDDK NIH HHS/United States
- UL1TR001111/TR/NCATS NIH HHS/United States
- DK082866/DK/NIDDK NIH HHS/United States
- DK082919/DK/NIDDK NIH HHS/United States
- P30 DK026743/DK/NIDDK NIH HHS/United States
- P30 DK050306/DK/NIDDK NIH HHS/United States
- M01 RR000040/RR/NCRR NIH HHS/United States
- DK082864/DK/NIDDK NIH HHS/United States
- U01 DK082923/DK/NIDDK NIH HHS/United States
- U01 DK082871/DK/NIDDK NIH HHS/United States
- U01 DK082944/DK/NIDDK NIH HHS/United States
- U01 DK082864/DK/NIDDK NIH HHS/United States
- DK082927/DK/NIDDK NIH HHS/United States
- UL1TR000058/TR/NCATS NIH HHS/United States
- UL1 TR002489/TR/NCATS NIH HHS/United States
- UL1RR024986/RR/NCRR NIH HHS/United States
- UL1 TR000058/TR/NCATS NIH HHS/United States
- DK082867/DK/NIDDK NIH HHS/United States
- P30DK50306/DK/NIDDK NIH HHS/United States
- ImNIH/Intramural NIH HHS/United States
- U01 DK082867/DK/NIDDK NIH HHS/United States
- U01 DK082843/DK/NIDDK NIH HHS/United States
- U01 DK082863/DK/NIDDK NIH HHS/United States
- DK082874/DK/NIDDK NIH HHS/United States
- DK082863/DK/NIDDK NIH HHS/United States
- DK082923/DK/NIDDK NIH HHS/United States
- UL1TR000004/TR/NCATS NIH HHS/United States
- A-DK-3002-001/DK/NIDDK NIH HHS/United States
- DK 082843/DK/NIDDK NIH HHS/United States
- U01 DK082874/DK/NIDDK NIH HHS/United States
- M01-RR00040/RR/NCRR NIH HHS/United States
- UL1 TR000004/TR/NCATS NIH HHS/United States
- U01 DK082866/DK/NIDDK NIH HHS/United States
- UL1 RR024986/RR/NCRR NIH HHS/United States
- DK082943/DK/NIDDK NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical